Treatment Set TS333519 is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Anthoxanthum Odoratum Pollen; Cynodon Dactylon Pollen; Lolium Perenne Pollen; Poa Pratensis Pollen; Sorghum Halepense Pollen; Dermatophagoides Pteronyssinus; Dactylis Glomerata Pollen; Ambrosia Artemisiifolia Pollen.
| Product ID | 49288-0680_89f9e682-acd9-4cc7-982d-c32f69b33b07 |
| NDC | 49288-0680 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Treatment Set TS333519 |
| Generic Name | Treatment Set Ts333519 |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1986-10-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | ANTHOXANTHUM ODORATUM POLLEN; CYNODON DACTYLON POLLEN; LOLIUM PERENNE POLLEN; POA PRATENSIS POLLEN; SORGHUM HALEPENSE POLLEN; DERMATOPHAGOIDES PTERONYSSINUS; DACTYLIS GLOMERATA POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN |
| Active Ingredient Strength | 4000 [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL; [AU]/mL; [BAU]/mL; [AU]/mL |
| Pharm Classes | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [CS],Insect Proteins [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1986-10-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1986-10-31 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| ANTHOXANTHUM ODORATUM POLLEN | 4000 [BAU]/mL |